Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma
- 24 December 2011
- journal article
- research article
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 188 (1) , 49-55
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- IMRT With Simultaneous Integrated Boost and Concurrent Chemotherapy for Locoregionally Advanced Squamous Cell Carcinoma of the Head and NeckInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Targeted therapy in head and neck cancerCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2011
- Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experienceHead & Neck Oncology, 2010
- Early clinical experience with volumetric modulated arc therapy in head and neck cancer patientsRadiation Oncology, 2010
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalThe Lancet Oncology, 2010
- HPV & head and neck cancer: a descriptive updateHead & Neck Oncology, 2009
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Severe skin reaction secondary to concomitant radiotherapy plus cetuximabRadiation Oncology, 2008
- Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): An UpdateInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Cetuximab combined with radiotherapy: An alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?European Journal of Cancer, 2007